Department of Health

Department of Health - Newborn Metabolic Screening

The effect of the rules will be to add severe combined immunodeficiency disorder (SCID) to the mandated newborn screening panel and ensure NBS specimens will not be used for any purpose other than for newborn screening for which they were collected. Deletions will remove language conflicting with current protocols and standard operating procedures for the services of a centralized designated contract laboratory for newborn screening.

New content is added below as the draft rules move through the rule-making process.

Intermin Rules Hearing
Agency Contact: Susan Sporrer
mail to:
Important Dates
Public Hearing:
Comment Deadline:
Interim Rules Committee Hearing:
Filed-Secretary of State:
Rule Effective: